TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Monoclonal Antibody Cocktail Authorized for Post-COVID Exposure REGEN-COV becomes first monoclonal antibody treatment with EUA following exposure alone Jul 30, 2021
Call in the T-Cell Cavalry to Fight COVID in the Immunocompromised Preliminary research suggests immunotherapy could play role in protecting vaccine non-responders Jul 29, 2021
More Medical Device Deaths Than We Previously Thought? Study finds many reports of patient deaths that were not classified as a death in FDA database Jul 27, 2021
Shingrix OK'd for Immunocompromised Adults CDC's vaccine committee currently discussing vaccine for this population, manufacturer says Jul 26, 2021
FDA Approves IVIG for Dermatomyositis Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
FDA Warns Doctors, Consumers on Contaminated Chantix Latest drug found with cancer-causing nitrosamines Jul 20, 2021
FDA Breaks New Ground With Transplant Drug Approval No prospective trial offered or required Jul 19, 2021
Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drug Advisory committee rejected oral anemia drug for dialysis and non-dialysis patient populations Jul 16, 2021
FDA Panel Nearly Unanimous on Liver Transplant Perfusion Device Thumbs up on safety and efficacy Jul 15, 2021
Company Shut Down Robot Mid-Surgery; Infected in Quarantine; Investigating Aduhelm This past week in healthcare investigations Jul 14, 2021
Juul Bought Out Medical Journal for $51K E-cig maker sponsored nearly a dozen studies, took over journal as it awaits FDA ruling Jul 13, 2021
Ivermectin and Aducanumab: Do They Work? ZDoggMD and Vinay Prasad, MD, MPH, analyze the evidence Jul 13, 2021
Walmart's Low-Price Insulin Is a Band-Aid on a Broken System Exorbitant drug pricing and inaccessible care require government intervention Jul 11, 2021
Finerenone OK'd for Slowing Kidney Disease in T2D Drug also indicated for cardiovascular event risk reduction Jul 09, 2021
Alzheimer's Aducanumab Prescribing Information Changes "We as neurologists need a strategy to advise our patients," experts say Jul 09, 2021
FDA Cannot Ban Use of Electric Shock Devices for Harmful Behaviors Appeals court rules in favor of only U.S. facility still using devices for behavioral treatment Jul 09, 2021
Is Confirmation Bias Guiding COVID Vaccine Recommendations? Policy must be based on indisputable evidence Jul 06, 2021
COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxed A daily roundup of news on COVID-19 and the rest of medicine Jul 06, 2021
CDC's All-or-Nothing Approach to Teen COVID Vaccination Is All Wrong The agency should revisit its latest guidance to maximize benefits and minimize risks Jun 29, 2021
Ranitidine Did Not Convert to Carcinogen in Two Small FDA Studies However, don't expect the drug's return to market anytime soon, say editorialists Jun 28, 2021
Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA ODAC recommends deferring approval of new PD-1 inhibitor until confirmatory trial results are in Jun 24, 2021
Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
The FDA Is Failing the American People The agency's recent decision to approve aducanumab offers more evidence of a broken system Jun 16, 2021
Docs, Scientists Call on FDA to Delay Approval of COVID Vaccines Data should be from completed phase III trials, not interim results, group says Jun 10, 2021
Op-Ed: Why Is Prescribing Information Still on Paper? Making electronic info the default is a small change with a big environmental impact Jun 04, 2021
Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
Guns for Vaccinations; IU Health Joins the Mandate Club; NFL Ends 'Race-Norming' A daily roundup of news on COVID-19 and the rest of medicine Jun 03, 2021
Novel Aid to Help Diagnose Autism Gets FDA Nod Canvas Dx device may help early diagnoses and intervention in young children Jun 02, 2021
FDA OKs New Antipsychotic for Schizophrenia, Bipolar Disorder Approval of olanzapine-samidorphan carries opioid-related contraindications Jun 01, 2021
Are Vaccine Advisors More Conflicted Than We Thought? Rules for advisory committee members' disclosures vary widely May 28, 2021
Drug to Delay T1D Gets Tepid Endorsement by FDA Advisors Feelings mixed on safety and efficacy evidence for novel biologic May 28, 2021
FDA Restricts Ocaliva Use in Primary Biliary Cholangitis Liver failure, need for liver transplant reported in patients with advanced cirrhosis May 27, 2021
Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
FDA Draft Guidance on T2D Devices; New GLP-1 Drug Succeeds in Trial News and commentary from the endocrinology world May 23, 2021
House Dems Grill Emergent Execs Over Spoiled J&J Doses Mixed-up ingredients, wasted taxpayer dollars, potential insider training? May 20, 2021
Indian Variant a Global Risk; Good News on U.S. Cases; Baylor Expert Gets Threats A daily roundup of news on COVID-19 and the rest of medicine May 11, 2021
First COVID Treatment Ads Hit the Airwaves Regeneron hoping patients ask their doctors about monoclonal antibodies May 10, 2021
FDA Panel to Weigh Avacopan's Fate for ANCA Vasculitis Agency staff called out "interpretability" of phase III trial results ahead of Thursday's meeting May 05, 2021
Judge Orders Hospital to Give COVID Patient Ivermectin Drug to be given to comatose Illinois patient after docs refused May 04, 2021
